Trials / Conditions / Giant Cell Tumor of Bone

Giant Cell Tumor of Bone

19 registered clinical trials studyying Giant Cell Tumor of Bone — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery NCT07315828	Shanghai Jiao Tong University Affiliated Sixth People's Hospital	Phase 4
Recruiting	PROMIS and Mobility Evaluation in Sarcoma Patients NCT07227961	University of Calgary	—
Recruiting	Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospect NCT06647901	Tang Xiaodong	Phase 1 / Phase 2
Active Not Recruiting	Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the B NCT04586660	Amgen	Phase 4
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone NCT05813665	Shanghai JMT-Bio Inc.	Phase 3
Recruiting	Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional C NCT05595603	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2
Completed	A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone NCT05402865	Shanghai JMT-Bio Inc.	—
Unknown	Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone NCT04255576	Shanghai JMT-Bio Inc.	Phase 1 / Phase 2
Completed	Giant Cell Tumor of the Bone in Young Patients NCT04002817	Istituto Ortopedico Rizzoli	—
Recruiting	Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone NCT03295981	St. Louis University	Phase 3
Active Not Recruiting	LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca NCT03449108	M.D. Anderson Cancer Center	Phase 2
Unknown	Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China NCT03358212	Peking University People's Hospital	—
Completed	Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 NCT03301857	Amgen	Phase 4
Unknown	Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone NCT03259152	Hebei Medical University Third Hospital	Phase 3
Completed	Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment NCT02996734	Istituto Ortopedico Rizzoli	—
Terminated	Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) NCT00889590	Leiden University Medical Center	Phase 2
Completed	Study of Denosumab in Subjects With Giant Cell Tumor of Bone NCT00680992	Amgen	Phase 2
Completed	Trial of Dasatinib in Advanced Sarcomas NCT00464620	Sarcoma Alliance for Research through Collaboration	Phase 2
Completed	Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone NCT00396279	Amgen	Phase 2